According to the British "Daily Mail" recently reported, Australian scientists have discovered that the new cholesterol-lowering drug Torcetrapib is being taken together with statins, which can significantly improve blood sugar control in patients with type 2 diabetes.
Torcetrapib aims to increase the concentration of "good" cholesterol, which stabilizes blood sugar levels and reduces the risk of heart disease and diabetes. Good cholesterol is very important because it slows arteriosclerosis and reduces the risk of heart attack.
The research team led by Philip Barth, director of the University of Sydney Institute of Cardiology and professor of medicine at the University of Sydney, conducted a study of 15,000 diabetic patients aged between 45 and 75 years old who suffered from heart attacks, strokes, and chest pains. History of peripheral vascular diseases.
Early experimental results showed that the degree of blood glucose control in 7,000 patients with type 2 diabetes has improved. The latest research was published in the American Heart Association's journal Circulation.
About 2.5 million Britons have type 2 diabetes, and overweight and lack of exercise can cause diabetes. Diabetes increases people's risk of heart disease, stroke and other heart diseases. Many patients use statins that lower cholesterol levels to treat them. Bart added that this experimental drug is not as effective as other drugs in the treatment of diabetes, but it can prevent the deterioration of diabetes when patients take large doses of statin drugs.
Scientists are also developing two other similar drugs, Dalcetrapib and anaecetrapib. A spokesman for the British Heart Foundation stated that it is too early to tell whether these two new drugs are effective.
Torcetrapib aims to increase the concentration of "good" cholesterol, which stabilizes blood sugar levels and reduces the risk of heart disease and diabetes. Good cholesterol is very important because it slows arteriosclerosis and reduces the risk of heart attack.
The research team led by Philip Barth, director of the University of Sydney Institute of Cardiology and professor of medicine at the University of Sydney, conducted a study of 15,000 diabetic patients aged between 45 and 75 years old who suffered from heart attacks, strokes, and chest pains. History of peripheral vascular diseases.
Early experimental results showed that the degree of blood glucose control in 7,000 patients with type 2 diabetes has improved. The latest research was published in the American Heart Association's journal Circulation.
About 2.5 million Britons have type 2 diabetes, and overweight and lack of exercise can cause diabetes. Diabetes increases people's risk of heart disease, stroke and other heart diseases. Many patients use statins that lower cholesterol levels to treat them. Bart added that this experimental drug is not as effective as other drugs in the treatment of diabetes, but it can prevent the deterioration of diabetes when patients take large doses of statin drugs.
Scientists are also developing two other similar drugs, Dalcetrapib and anaecetrapib. A spokesman for the British Heart Foundation stated that it is too early to tell whether these two new drugs are effective.
Surgery Table Mattress,Surgery Table Foaming Pad,Surgery Table Buckle Belt,General Surgery Accessories
NINGBO TECHART MEDICAL EQUIPMENT CO.,LTD , https://www.techartmed.com